Home / Stocks / IRD

IRD insider trading

Opus Genetics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
4
Bought · 24 mo
$533k
Buys · last 90 days
0 · $0
Most recent buy
2025-12-31

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-05-20Foundation Fighting Blindness Retinal Degeneration Fund
Director
Sold1,700,000$4.35$7.4M
2025-12-31Gallagher Cam
Director
Bought164,000$1.97$324k
2025-12-11Foundation Fighting Blindness Retinal Degeneration Fund
Director
Sold4,000,000$2.15$8.6M
2024-12-30Magrath George
Chief Executive Officer
Bought100,000$0.98$98k
2024-11-25YERXA BENJAMIN R
President
Bought10,000$0.98$10k
2024-11-19Magrath George
Chief Executive Officer
Bought100,000$1.01$101k

Most active insider buyers

InsiderRoleBuysTotal bought
Gallagher CamDirector1$324k
Magrath GeorgeChief Executive Officer2$199k
YERXA BENJAMIN RPresident1$10k

See IRD on the chart

Every insider buy and sell for IRD plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.